Natural polyphenolic compounds to enhance testosterone production and prevent age-related hypogonadism in aging males.
MoonLake’s PhII data on skin disease set it up against Cosentyx, UCB and others in IL-17 field
MoonLake Immunotherapeutics says it’s cleared the bar in a Phase II trial of its IL-17A and IL-17F inhibitor in hidradenitis suppurativa. In its 234-patient MIRA